Table 1.
Pre | Post | P value | |
---|---|---|---|
Body weight | 100 ± 10 | 90 ± 2 | 0.0003 |
BMI | 27 ± 1.5 | 25 ± 1.8 | 0.0001 |
Total-C, mg/dL | 200 ± 10 | 159 ± 7 | 0.0001 |
LDL-C, mg/dL | 109 ± 5 | 84 ± 4 | 0.0001 |
HDL-C, mg/dL | 44 ± 3 | 39 ± 5 | 0.0005 |
TG, mg/dL | 110 ± 5 | 111 ± 7 | — |
Blood glucose, mg/dL | 100 ± 5 | 92 ± 9 | 0.0013 |
AST-GOT | 23 ± 2 | 17.5 ± 0.5 | 0.0001 |
ALT-GPT | 28 ± 0.5 | 19.1 ± 0.3 | 0.0001 |
LDH | 305 ± 5 | 300 ± 8 | 0.0230 |
TBARS μM/μg protein | 0.0017 | 0.00076 | 0.0156 |
NO nmol/μg protein | 0.00048 | 0.00073 | 0.0052 |
SOD activity U/μg protein | 0.0009 | 0.0014 | 0.0465 |
All data are expressed as means ± SE (n = 20 subjects). BMI: body mass index; Total-C: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TBARS: thiobarbituric acid reactive substance; NO: nitric oxide; SOD: superoxide dismutase. P value was evaluated according to “Pre” versus “Post” intervention.